WHO ICTRP trial
Investigating the effect and safety of NEERI® Tablet and Syrup on kidney stones
CTRI/2023/07/054784 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/07/054784 |
|---|---|
| Public title | Investigating the effect and safety of NEERI® Tablet and Syrup on kidney stones |
| Scientific title | An open-label, randomized, single center prospective study to evaluate the efficacy & safety of a polyherbal NEERI® Tablet and Syrup in patients with renal calculi disease - NIL |
| Primary sponsor | Aimil Pharmaceuticals (India) Ltd. |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: N200- Calculus of kidney |
| Registration date | May 7, 2023 |
| Target size | 30 |
| Secondary IDs | AIMIL/001/2023 Version No. 1.0 Dated 27 May 2023 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: